A citation-based method for searching scientific literature




Erik L Meredith, Ophelia Ardayfio, Kimberly Beattie, Markus R Dobler, Istvan Enyedy, Christoph Gaul, Vinayak Hosagrahara, Charles Jewell, Keith Koch, Wendy Lee, Hansjoerg Lehmann, Timothy A McKinsey, Karl Miranda, Nikos Pagratis, Margaret Pancost, Anup Patnaik, Dillon Phan, Craig Plato, Ming Qian, Vasumathy Rajaraman, Chang Rao, Olga Rozhitskaya, Thomas Ruppen, Jie Shi, Sarah J Siska, Clayton Springer, Maurice van Eis, Richard B Vega, Anette von Matt, Lihua Yang, Taeyoung Yoon, Ji-Hu Zhang, Na Zhu, Lauren G Monovich. J Med Chem 2010
Times Cited: 38




List of shared articles



Times cited

A targeted library screen reveals a new inhibitor scaffold for protein kinase D.
Manuj Tandon, Lirong Wang, Qi Xu, Xiangqun Xie, Peter Wipf, Qiming Jane Wang. PLoS One 2012
11

Protein kinase D isoforms: new targets for therapy in invasive breast cancers?
Sahra Borges, Peter Storz. Expert Rev Anticancer Ther 2013
9

Discovery of diverse small molecule chemotypes with cell-based PKD1 inhibitory activity.
Elizabeth R Sharlow, Gabriela Mustata Wilson, David Close, Stephanie Leimgruber, Manuj Tandon, Robyn B Reed, Tong Ying Shun, Q Jane Wang, Peter Wipf, John S Lazo. PLoS One 2011
18

Design, Synthesis, and Biological Evaluation of PKD Inhibitors.
Kara M George, Marie-Céline Frantz, Karla Bravo-Altamirano, Courtney R Lavalle, Manuj Tandon, Stephanie Leimgruber, Elizabeth R Sharlow, John S Lazo, Q Jane Wang, Peter Wipf. Pharmaceutics 2011
37

Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases.
Xuejing Zhang, Jaclyn Connelly, Yapeng Chao, Qiming Jane Wang. Biomolecules 2021
15

Protein kinase D signaling in cancer: A friend or foe?
Adhiraj Roy, Jing Ye, Fan Deng, Qiming Jane Wang. Biochim Biophys Acta Rev Cancer 2017
37

Protein kinase d as a potential chemotherapeutic target for colorectal cancer.
Ning Wei, Edward Chu, Peter Wipf, John C Schmitz. Mol Cancer Ther 2014
37

Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyrimidine-based protein kinase D inhibitors.
Philippe Gilles, Rudra S Kashyap, Maria João Freitas, Sam Ceusters, Koen Van Asch, Anke Janssens, Steven De Jonghe, Leentje Persoons, Mathias Cobbaut, Dirk Daelemans,[...]. Eur J Med Chem 2020
8

Protein kinase D2: a versatile player in cancer biology.
Ninel Azoitei, Mathias Cobbaut, Alexander Becher, Johan Van Lint, Thomas Seufferlein. Oncogene 2018
10

The oncogenic role of protein kinase D3 in cancer.
Yan Liu, Hang Song, Yehui Zhou, Xinxing Ma, Jing Xu, Zhenghong Yu, Liming Chen. J Cancer 2021
4

Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.
Nisha Durand, Sahra Borges, Peter Storz. Cell Mol Life Sci 2015
21

Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c-MYC axis in breast cancer.
Yan Liu, Hang Song, Shiyi Yu, Kuo-Hsiang Huang, Xinxing Ma, Yehui Zhou, Shuang Yu, Jingzhong Zhang, Liming Chen. J Cell Mol Med 2020
10

Unveiling the Structural Insights into the Selective Inhibition of Protein Kinase D1.
Raju Dash, Md Arifuzzaman, Sarmistha Mitra, Md Abdul Hannan, Nurul Absar, S M Zahid Hosen. Curr Pharm Des 2019
11

New pyrazolopyrimidine inhibitors of protein kinase d as potent anticancer agents for prostate cancer cells.
Manuj Tandon, James Johnson, Zhihong Li, Shuping Xu, Peter Wipf, Qiming Jane Wang. PLoS One 2013
19